Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 1.3B | 1.5B | 1.2B | 1.2B |
Cost of revenue | 182.8M | 220.5M | 176.3M | 177.7M |
Gross profit | 1.1B | 1.3B | 1.0B | 1.0B |
Operating expense | ||||
Research & development | 470.2M | 434.0M | 454.1M | 402.8M |
Selling general and admin | 321.5M | 365.2M | 352.6M | 318.8M |
Other operating expenses | 11.7M | 21.2M | 11.1M | 8.5M |
Operating income | 348.1M | 521.1M | 263.3M | 299.6M |
Non operating interest income | ||||
Income | 1.8M | 1.7M | 3.0M | 5.7M |
Expense | 742.4K | 2.0M | 2.1M | 2.2M |
Other income expense | — | — | — | — |
Pretax income | 419.2M | 649.9M | 331.9M | 379.3M |
Tax provision | 24.8M | 34.6M | 14.0M | 22.7M |
Net income | 394.4M | 615.3M | 318.0M | 356.6M |
Basic EPS | 0.9 | — | — | — |
Diluted EPS | 0.9 | — | — | — |
Basic average shares | 463.0M | — | — | — |
Diluted average shares | 463.0M | — | — | — |
EBITDA | 419.5M | 685.4M | 334.2M | 390.2M |
Net income from continuing op. | — | — | — | — |
Minority interests | 8.4M | -10.1M | 467.8K | -2.2M |
Preferred stock dividends | 0 | 0 | 0 | 0 |